MLMonika Liptáková

Monika Liptáková

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Monika Liptáková has a total of 23 co-authors. Here are the top co-authors by number of shared publications:

  • Jan Kynčl

    Department of Infectious Diseases Epidemiology, Centre for Epidemiology and Microbiology, National Institute of Public Health, Prague, Czech Republic

    3 shared publications
  • Michaela Spackova

    Department of Infectious Diseases Epidemiology, Centre for Epidemiology and Microbiology, National Institute of Public Health, Prague, Czech Republic

    3 shared publications
  • Jan Kynčl

    Centre for Epidemiology and Microbiology, Department of Infectious Diseases Epidemiology, National Institute of Public Health, Prague, Czech Republic

    2 shared publications
  • Jana Košťálová

    National Institute of Public Health, Prague, Czechia

    2 shared publications
  • Marek Malý

    Department of Biostatistics, National Institute of Public Health, Prague, Czech Republic

    2 shared publications
  • Marek Malý

    Department of Biostatistics, National Institute of Public Health, Prague, Czech Republic

    2 shared publications

Latest Publications

  • Open Access

    Measles – retrospective study of cases reported in a national notification system, Czech Republic, 2018–2024

    by Monika Liptáková, Marek Malý, Michaela Špačková, Radomíra Limberková, Lada Svobodová, Jan Kynčl

    Background: In response to the recent increase in measles cases and outbreaks across Europe, Czech surveillance data were analysed. The aim was also to evaluate the effect of vaccination on measles complications. Methods: Cases of measles reported to the national surveillance system according to the EU case definition (2018) between 2018–2024, were analysed. Demographic characteristics were assessed using descriptive analysis (counts and proportions). Logistic regression with an odds ratio (OR) supplemented with the 95% confidence interval (95% CI) was calculated to measure the association between vaccination status and the occurrence of complications. Results: A total of 791 measles cases were reported during the study period, of which 762 (96%) were laboratory confirmed, 29 (4%) were probable and 416 (53%) were male. Most cases (546; 69%) occurred in 2019. Half of the cases ( n = 395, 50%) were outbreak related. The median age of cases was 33 years (range: 0–54). In total, 109 (14%) measles cases were imported (62 from Ukraine and smaller numbers from 25 other countries; 57 of the imported cases were unvaccinated) and 523 cases (70%) were hospitalised. In total, 330 (42%) of all cases were known to have been vaccinated, of which 205 (62%) with two or three doses and 75 (23%) with only one dose. Of 88 complications (11% of all cases) was pneumonia most frequent (n = 19; 2%). The highest proportion of complications occurred in infants (< 1 year [too young to be vaccinated]; 28%) and in children aged 1–4 years (20%). Compared to unvaccinated cases, two and more vaccine doses significantly reduced odds of any complications (OR = 0.44, 95% CI: 0.24–0.81, p = 0.008). Conclusions: Within analysed 7-year period most cases were detected pre-pandemic in 2018 and 2019. It is likely that restrictive measures limited further epidemic potential. Isolation of measles case is mandatory in Czech Republic; therefore, this criterion does not reflect the clinical severity of cases. Having this limitation in mind, the effect of vaccination against measles complications only was demonstrated. To prevent further cases, increased awareness and promotion of measles vaccination is recommended for all individuals, including travellers, as a substantial proportion of cases were unvaccinated.


  • Open Access

    Epidemiology of human salmonellosis in Czechia ─ a country with the highest European notification rate, 2012 to 2023

    by Michaela Špačková, Monika Liptáková, OndřEj Daniel, Veronika Vlasáková, Jana Košťálová, Jan Kynčl

    BACKGROUND: Salmonellosis is the second most notified food-borne infection in Europe. In Czechia (CZ), the notification rate has consistently been above the European average, five times higher in 2013–2022. AIM: We aimed to describe the epidemiology of salmonellosis in CZ in 2012–2023 and identify areas for improving surveillance and public health actions. METHODS: We extracted data on notified salmonellosis cases from the national surveillance system and analysed the dataset for demographic characteristics, hospitalisation, transmission mode and suspected vehicle, descriptively and by chi-square tests and logistic regression. RESULTS: In 2012–2023, 130,990 cases (102.7/100,000 inhabitants) were notified. The overall annual notification rate decreased from 111.7 per 100,000 in 2012–2017 to 94.2 per 100,000 in 2018–2023. Most cases were children and adolescents aged < 15 years (n = 68,370; 52.2%) and most were females (n = 68,425; 52.2%) but males dominated among cases aged < 15 years (35,790/68,370; 52.3%). Few cases were imported (n = 2,627; 2.0%) or outbreak-related (n = 5,361; 4.1%); most were diagnosed in June–October (n = 83,057; 63.4%). Of all notified cases, 22.2% (n = 29,082) were hospitalised. Age of ≥ 40 years was associated with hospitalisation and Salmonella sepsis (p < 0.001). Transmission mode was identified for 59,729 (45.6%) cases. CONCLUSION: Despite a decline, the notification rates of salmonellosis remain high in CZ. The effectiveness of the surveillance system is reflected in relatively low hospitalisation rates compared with some other European countries, yet the source and transmission mode were unidentified in over half of the cases. We encourage enhancing epidemiological investigations, improving sample submission to the National Reference Laboratory and molecular surveillance.

  • Open Access

    Monitoring the Effect of Vaccination on Mumps Cases Complications in the Czech Republic - Surveillance Data 2013–2022

    by Monika Liptáková, Marek Malý, Hana Orlíková, Michaela Špačková, Radomíra Limberková, Jan Kynčl

    Introduction: Mumps data were analysed to assess the effect of vaccination on mumps complications and hospitalisation. Methods: The mumps cases reported to the Czech nationwide surveillance system from 2013 to 2022 were analysed using logistic regression with an odds ratio (aOR) adjusted for age, sex, year of onset and administrative region to measure the association between vaccination and complications or hospitalisation. Adjusted vaccine effectiveness (aVE) was calculated: aVE=(1-aOR)x100. Results: A total of 11,913 mumps cases were reported, of which 6,885 (58%) were male. The median age of the study participants was 16 (range: 0–89 years). No complications occurred in 91% of patients. Mumps orchitis occurred in 633 (9%) male cases. A total of 946 (8%) patients required hospitalisation. The highest proportion of complications and hospitalisations was in the age group 35–44 years. Two doses of vaccine reduced statistically significantly the risk of any complications and of hospitalisation compared with unvaccinated patients: aOR 0.48 (95% CI: 0.37, 0.62), aVE of 52% (95% CI: 38, 63); and aOR 0.43 (95% CI: 0.33, 0.56), aVE of 57% (95% CI: 44, 67), respectively. Two doses showed statistically significant aVE 50% (95% CI: 32, 64) against orchitis, and 59% (95% CI: 23, 79) against meningitis. Among the two-dose recipients, the proportion of complications increased gradually with the time from the second dose. Conclusions: Our findings demonstrated a protective effect of two-dose vaccination against mumps complications and hospitalisation for mumps. We recommend continuing routine childhood mumps vaccination and maintaining high MMR coverage in Czechia.


  • Open Access

    Vaccination against influenza in pregnant women in a maternity hospital in the Czech Republic in the season 2020–2021

    by Jan Kynčl, Monika Liptáková, Jana Košťálová, Marek Malý, Marcela Křížová, Hynek Heřman, Kateřina Fabiánová

    Pregnant women are among the priority groups to receive influenza vaccines in the Czech Republic since 2011, data on vaccination coverage are not yet available. The aim of the study was to determine the influenza vaccination coverage (IVC) and provide source data for further activities. A prospective observational study was performed in a large maternity hospital in Prague. The self-completed questionnaire was distributed to 5,475 pregnant women between September 1, 2020 and August 31, 2021. Questions included maternal sociodemographic characteristics, influenza vaccination status and sources of maternal vaccination recommendations during pregnancy. A total of 4,617 completed questionnaires have been analysed. The median age of study participants (N = 4,592) was 33 years (range: 18–51 years). The majority (69.7%) of women had completed their university education, most women were childless (58.5%) or had one child (32.5%) before the start of the study. Less than 2% of women reported being vaccinated against influenza during their pregnancy (1.5%; 95% CI, 1.1–1.9%). Only 21% of women knew that it’s possible to get vaccinated against influenza during pregnancy. Participants considered influenza vaccination in pregnancy as important (3.3%), useful (41.1%) and useless (44.4%). Out of 959 pregnant women who had information about influenza vaccination during pregnancy, only 6.9% were vaccinated, while among those who did not have this information, 0.1% were vaccinated during pregnancy (p < 0.001). The most frequent source of information was Internet, then media and a general practitioner. The IVC during pregnancy in our study was extremely low. In order to improve IVC among pregnant women, it is necessary to increase awareness of recommendations and vaccination options among the public and professionals and incorporating vaccination recommendation in routine antenatal practice.


  • Open Access

    Evaluation of the Completeness and Timeliness of the Infant Pertussis Surveillance System in the Czech Republic in 2015, 2017 and 2019

    by Monika Liptáková, Michaela Špačková, Sooria Balasegaram, Marek Malý, Jan Kynčl, Kateřina FABIÁNOVÁ

    Introduction: The completeness and timeliness of the pertussis questionnaire-based enhanced surveillance system (ESS) among infants and reported pertussis data within the electronic nationwide notification system (NNS) in the years 2015, 2017 and 2019 were evaluated in a pilot study. Methods: The completeness of the variables for demographic characteristics, date of symptom onset, hospitalisation and vaccination status were assessed in both systems. Timeliness of reporting in the NNS was analysed as the interval between symptom onset and a) the date of first specimen collection (diagnostic delay), and b) the date of the Regional Public Health Authority receiving notification (notification delay). Results: A total of 121 confirmed pertussis cases were reported to the NNS in the study years, while in the ESS a total of 104 confirmed cases were reported in infants. In both systems most cases were in the age group of one completed month of life (20% versus 23%) and males (55% versus 55%). The majority of cases were hospitalised (81% versus 85%) and unvaccinated (77% versus 78%). Within the NNS, the first dose of vaccine was reported in 13 cases, the second dose in 11, and third dose in three cases. Within the NNS, 100% completeness of following variables was found: symptom onset, week and region of reporting, age, gender and place of isolation. Median diagnostic delay was nine days. Median notification delay was 18 days. Conclusions: Data completeness was high in the NNS, except for lack of vaccination data in those eligible by age. Efforts to improve the completeness of laboratory-related variables and timeliness are essential. Based on the study results, the project of improving the ESS for infants will continue with regular evaluation.

    • 1 January 2022
      • Vol. 71  (3) , 139-147

    What risk factors affect hospitalisation for confirmed pertussis cases among infants in the Czech Republic?

    by M. Liptakova, M. Spackova, S. Balasegaram, M. Maly, J. Kyncl, K. Fabianova

    Background: We estimated what riskfactors affect hospitalisation for confirmed pertussis cases among infants (child up to 1 year) in the Czech Republic based on data from the questionnaire-based enhanced surveillance system (ESS) in years 2015, 2017 and 2019. Methods: Retrospective cohort study was conducted in which we assessed demographic, clinical data, vaccination status and risk/protective factors. Vaccination status was extracted from the electronic nationwide notification system (NNS). We performed descriptive, univariable and multivariable analysis using risk ratio (RR) and logistic regression with odds ratio (OR). Results: A total of 104 confirmed cases (27, 13, 64) were reported in the ESS during 2015, 2017 and 2019. Most cases were in age group 1 month (24), more males (57). Fifteen cases were vaccinated and 89 unvaccinated. Of 88 hospitalised cases, 31 cases reported stay in Intensive Care Unit (ICU). The median length of hospitalisation was 8 days. Although the variable vaccinated in infants was statistically significant in a univariable analysis for outcome hospitalisation, RR 0.76 (95% CI 0.53-1.10), it was not in multivariable. Hospitalisation was strongly associated with the younger age group of 0-3 months adjusted by a smoking family member in a household (OR = 9.72; 95% CI: 2.97-31.81). Stay in ICU was strongly correlated with the younger age group of 0-3 months (OR = 5.07; 95% CI: 1.44-17.87) and with a contact with confirmed or probable pertussis (OR = 7.05; 95% CI: 1.36-36.52). Conclusions: Our study demonstrated younger age and contact with other pertussis case as risk factors for hospitalisation of infants with pertussis. It is necessary to consider adolescent and adult boosters, including vaccination during pregnancy. We suggest integrating the variables from the enhanced surveillance system into the nationwide notification system, in order to simplify the data reporting and evaluation. Further studies are needed to evaluate the ESS and to monitor the vaccination of pregnant women against pertussis.